Phase I clinical trial evaluating dual-targeting CAR-T cells (KD-496) against CLDN18.2 and NKG2DL in advanced gastrointestinal cancers and pancreatic cancers.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Peking University Cancer Hospital
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162502534
Cites:
Cited by:
Related to: